LabGenius Therapeutics

LabGenius TherapeuticsLabGenius Therapeutics
LabGenius Therapeutics

LabGenius Therapeutics

AI-driven drug discovery platform for rapid development of novel therapeutics.

Website
DR 462019ActiveLondon, United Kingdom
Rate
Advertise here

About

LabGenius Therapeutics is an AI-driven drug discovery company that leverages its proprietary platform to accelerate the development of novel therapeutics. Their approach combines advanced machine learning with high-throughput experimentation to identify and optimize drug candidates more efficiently than traditional methods.
Frequently asked

What does LabGenius Therapeutics do?

LabGenius Therapeutics is an AI-driven drug discovery company that leverages its proprietary platform to accelerate the development of novel therapeutics. Their approach combines advanced machine learning with high-throughput experimentation to identify and optimize drug candidates more efficiently than traditional methods.

What is LabGenius Therapeutics's revenue?

StartupHub estimates LabGenius Therapeutics's annual revenue at $469K (range $176K to $1.3M, 28% confidence), based on comparable companies in the sector.

What is LabGenius Therapeutics's valuation?

StartupHub estimates LabGenius Therapeutics's effective valuation at $11.9M (range $7.5M to $18.0M, 10% confidence), based on comparable companies in the sector.

How much funding has LabGenius Therapeutics raised?

LabGenius Therapeutics has raised a total of $3M in funding. The most recent round on record is Seed.

Where is LabGenius Therapeutics headquartered?

LabGenius Therapeutics is headquartered in London, United Kingdom.

When was LabGenius Therapeutics founded?

LabGenius Therapeutics was founded in 2019.

What industry does LabGenius Therapeutics operate in?

LabGenius Therapeutics operates in Biotech, Drug Discovery, AI-Driven Protein Design, HealthTech, Foundation Model, Generative AI.

Comments

No comments yet. Be the first to share your take.